Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIRBANIBULIN Cause Application site dryness? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Application site dryness have been filed in association with TIRBANIBULIN (Klisyri). This represents 5.1% of all adverse event reports for TIRBANIBULIN.

10
Reports of Application site dryness with TIRBANIBULIN
5.1%
of all TIRBANIBULIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Application site dryness From TIRBANIBULIN?

Of the 10 reports.

Is Application site dryness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIRBANIBULIN. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does TIRBANIBULIN Cause?

Drug ineffective (44) Application site erythema (31) Drug intolerance (20) Erythema (18) Adverse drug reaction (17) Application site exfoliation (17) Application site vesicles (14) Application site pain (12) Off label use (11) Application site pruritus (9)

What Other Drugs Cause Application site dryness?

MINOXIDIL (1,027) INGENOL MEBUTATE (365) SUMATRIPTAN (208) BUPRENORPHINE (100) TESTOSTERONE (63) ADAPALENE (60) DICLOFENAC (55) ESTRADIOL (52) ESTRADIOL\NORETHINDRONE (49) NICOTINE (48)

Which TIRBANIBULIN Alternatives Have Lower Application site dryness Risk?

TIRBANIBULIN vs TIROFIBAN TIRBANIBULIN vs TIRZEPATIDE TIRBANIBULIN vs TISAGENLECLEUCEL TIRBANIBULIN vs TISLELIZUMAB TIRBANIBULIN vs TISOTUMAB VEDOTIN

Related Pages

TIRBANIBULIN Full Profile All Application site dryness Reports All Drugs Causing Application site dryness TIRBANIBULIN Demographics